Evidence map›Paper›PMID 41783750›Full record

ArticleInternational journal of women's health2026

Protocol-Specific Luteinizing Hormone Thresholds for IVF Pregnancy Outcomes: The Moderating Role of Age in a Retrospective Study of 217 Cycles.

Jiahui Zhao, Huijuan Guan, Mei Wang, Lisha Tang, Huaiyun Tang

Abstract read
In one paragraph

Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jiahui ZhaoDepartment of Reproductive Medicine, Lianyungang Maternal and Child Health Hospital, Lianyungang, Jiangsu, People's Republic of China.
Huijuan GuanDepartment of Reproductive Medicine, Lianyungang Maternal and Child Health Hospital, Lianyungang, Jiangsu, People's Republic of China.
Mei WangDepartment of Reproductive Medicine, Lianyungang Maternal and Child Health Hospital, Lianyungang, Jiangsu, People's Republic of China.
Lisha TangDepartment of Reproductive Medicine, Lianyungang Maternal and Child Health Hospital, Lianyungang, Jiangsu, People's Republic of China.
Huaiyun TangDepartment of Reproductive Medicine, Lianyungang Maternal and Child Health Hospital, Lianyungang, Jiangsu, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To explore the impact of trigger-day luteinizing hormone (LH) levels on pregnancy outcomes in antagonist and long protocols during in vitro fertilization (IVF) and determine protocol-specific LH thresholds. Methods: This retrospective analysis covered 217 IVF/ICSI cycles from January 2023 to April 2024. The relationships between trigger-day LH levels and pregnancy outcomes in the two protocols were compared using ROC curves, multivariate logistic regression, and mediation models. Results: In the antagonist protocol, LH > 1.45 IU/L was linked to lower oocyte yield, reduced high-quality embryo rates, and a higher risk of clinical pregnancy failure (RR = 2.34, p = 0.006). In the long protocol, LH > 1.0 IU/L was associated with higher clinical pregnancy rates (OR = 2.61, p = 0.026), with 68% of the effect mediated by increased oocyte yield. Age ≤ 35 significantly enhanced these effects (three-way interaction OR = 6.55, p = 0.003). Conclusion: The antagonist and long protocols should adopt LH thresholds of 1.45 IU/L and 1.0 IU/L, respectively. Age is a key moderator, providing evidence for individualized IVF trigger strategies.

Indexed as

age interactionantagonist protocolclinical pregnancyin vitro fertilizationlong protocolluteinizing hormone

Identifiers

PMID41783750
PMCPMC12954015

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.